D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 79 Citations 21,284 544 World Ranking 12436 National Ranking 373

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Disease

Pascal Joly focuses on Internal medicine, Dermatology, Psoriasis, Pathology and Surgery. His biological study spans a wide range of topics, including Gastroenterology and Oncology. His Dermatology study integrates concerns from other disciplines, such as Paraneoplastic pemphigus, Bullous pemphigoid and Disease.

His study in the fields of Psoriatic arthritis under the domain of Psoriasis overlaps with other disciplines such as Risk assessment. His work on Lymphoma, Lymph and Cutaneous lymphoma as part of general Pathology study is frequently linked to Plasmacytoid dendritic cell, therefore connecting diverse disciplines of science. Within one scientific family, Pascal Joly focuses on topics pertaining to Confidence interval under Surgery, and may sometimes address concerns connected to Odds ratio, Risk factor and Immunopathology.

His most cited work include:

  • A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid (388 citations)
  • A Single Cycle of Rituximab for the Treatment of Severe Pemphigus (341 citations)
  • A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma (339 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Dermatology, Internal medicine, Pathology, Immunology and Pemphigus. His Dermatology research includes elements of Bullous pemphigoid and Disease. Pascal Joly interconnects Gastroenterology, Surgery and Oncology in the investigation of issues within Internal medicine.

His work carried out in the field of Pemphigus brings together such families of science as Pemphigus vulgaris, Autoimmune disease, Prednisone, Rituximab and Paraneoplastic pemphigus. He focuses mostly in the field of Pemphigus vulgaris, narrowing it down to matters related to Pemphigus foliaceus and, in some cases, Desmoglein 1. Pascal Joly has included themes like Systematic review and Physical therapy in his Psoriasis study.

He most often published in these fields:

  • Dermatology (26.89%)
  • Internal medicine (17.44%)
  • Pathology (16.18%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (17.44%)
  • Dermatology (26.89%)
  • Pemphigus (15.34%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Dermatology, Pemphigus, Rituximab and Immunology are his primary areas of study. His Internal medicine study combines topics in areas such as Gastroenterology and Psoriasis. His Dermatology research is multidisciplinary, incorporating perspectives in Paraneoplastic pemphigus, Mycosis fungoides and Incidence.

His Pemphigus research incorporates themes from Corticosteroid, Pemphigoid and Pemphigus vulgaris. His Rituximab study combines topics from a wide range of disciplines, such as Tumor necrosis factor alpha, Regimen, B cell and Prednisone. His work on Desmoglein, Autoantibody, Antibody and Bullous pemphigoid is typically connected to Drug reaction with eosinophilia and systemic symptoms as part of general Immunology study, connecting several disciplines of science.

Between 2017 and 2021, his most popular works were:

  • Diagnosis and management of pemphigus: Recommendations of an international panel of experts (100 citations)
  • Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial (87 citations)
  • Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management. (66 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

The scientist’s investigation covers issues in Internal medicine, Pemphigus, Rituximab, Pemphigus vulgaris and Gastroenterology. The various areas that Pascal Joly examines in his Pemphigus study include B cell, 2019-20 coronavirus outbreak, Venereology and Virology. His study looks at the intersection of Rituximab and topics like Prednisone with Regimen.

His Pemphigus vulgaris study is related to the wider topic of Dermatology. His Dermatology research is multidisciplinary, incorporating elements of Cross-sectional study and Hidradenitis suppurativa. His Bullous pemphigoid research incorporates elements of Epidermolysis bullosa, Mucous membrane and Pathology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid

Pascal Joly;Jean-Claude Roujeau;Jacques Benichou;Catherine Picard.
The New England Journal of Medicine (2002)

642 Citations

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

Corine Bertolotto;Fabienne Lesueur;Sandy Giuliano;Thomas Strub.
Nature (2011)

526 Citations

A Single Cycle of Rituximab for the Treatment of Severe Pemphigus

Pascal Joly;Hugo Mouquet;Jean-Claude Roujeau;Michel D'Incan.
The New England Journal of Medicine (2007)

492 Citations

High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL

Alisa M. Goldstein;May Chan;Mark Harland;Elizabeth M. Gillanders.
Cancer Research (2006)

457 Citations

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.

Pascal Joly;Maud Maho-Vaillant;Catherine Prost-Squarcioni;Vivien Hebert.
The Lancet (2017)

456 Citations

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Multiorgan Antiviral T Cell Response

Damien Picard;Baptiste Janela;Vincent Descamps;Michel D’Incan.
Science Translational Medicine (2010)

376 Citations

Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.

C. Horreau;C. Pouplard;E. Brenaut;T. Barnetche.
Journal of The European Academy of Dermatology and Venereology (2013)

358 Citations

Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.

Tony Petrella;Martine Bagot;Rein Willemze;Marie Beylot-Barry.
American Journal of Clinical Pathology (2005)

348 Citations

Incidence and Mortality of Bullous Pemphigoid in France

Pascal Joly;Sophie Baricault;Agnès Sparsa;Philippe Bernard.
Journal of Investigative Dermatology (2012)

344 Citations

Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases

B Vergier;A de Muret;M Beylot-Barry;L Vaillant.
Blood (2000)

321 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Pascal Joly

Enno Schmidt

Enno Schmidt

University of Lübeck

Publications: 120

Detlef Zillikens

Detlef Zillikens

University of Lübeck

Publications: 115

Takashi Hashimoto

Takashi Hashimoto

Osaka Metropolitan University

Publications: 71

Ralf Ludwig

Ralf Ludwig

University of Lübeck

Publications: 61

Rein Willemze

Rein Willemze

Leiden University Medical Center

Publications: 60

Martine Bagot

Martine Bagot

Université Paris Cité

Publications: 41

Lorenzo Cerroni

Lorenzo Cerroni

Medical University of Graz

Publications: 37

Victoria P. Werth

Victoria P. Werth

University of Pennsylvania

Publications: 37

Carle Paul

Carle Paul

Federal University of Toulouse Midi-Pyrénées

Publications: 36

Reinhard Dummer

Reinhard Dummer

University of Zurich

Publications: 36

Masayuki Amagai

Masayuki Amagai

Keio University

Publications: 35

Brigitte Bressac-de Paillerets

Brigitte Bressac-de Paillerets

Institut Gustave Roussy

Publications: 34

Mark Lebwohl

Mark Lebwohl

Icahn School of Medicine at Mount Sinai

Publications: 34

Hiroshi Shimizu

Hiroshi Shimizu

Hokkaido University

Publications: 31

Alisa M. Goldstein

Alisa M. Goldstein

National Institutes of Health

Publications: 31

Steven R. Feldman

Steven R. Feldman

Wake Forest University

Publications: 30

Trending Scientists

Rajni V. Patel

Rajni V. Patel

University of Western Ontario

Tao Jiang

Tao Jiang

Huazhong University of Science and Technology

Baojun Bai

Baojun Bai

Missouri University of Science and Technology

Xubiao Luo

Xubiao Luo

Nanchang Hangkong University

Jie Ren

Jie Ren

Tongji University

Markus Grompe

Markus Grompe

Oregon Health & Science University

Per Gundersen

Per Gundersen

University of Copenhagen

Wolf-Meinhard Becker

Wolf-Meinhard Becker

German Center for Lung Research

Eric T. Harvill

Eric T. Harvill

University of Georgia

Lee R. Lynd

Lee R. Lynd

Dartmouth College

Steve Elgar

Steve Elgar

Woods Hole Oceanographic Institution

Audrey de Nazelle

Audrey de Nazelle

Imperial College London

Thian Yew Gan

Thian Yew Gan

University of Alberta

Amir H. Pakpour

Amir H. Pakpour

Jönköping University

Per Ljungman

Per Ljungman

Karolinska University Hospital

Ansgar W. Lohse

Ansgar W. Lohse

Universität Hamburg

Something went wrong. Please try again later.